HCW Biologics Inc. financial data

Symbol
HCWB on Nasdaq
Location
Miramar, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 11% % -52%
Debt-to-equity -734% % -141%
Return On Equity 276% %
Return On Assets -43% % 67%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,701,607 shares -93%
Common Stock, Value, Issued $262 USD -93%
Weighted Average Number of Shares Outstanding, Basic 2,260,068 shares 139%
Weighted Average Number of Shares Outstanding, Diluted 2,260,068 shares 139%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue $337,620 USD -86%
Research and Development Expense $5,159,393 USD -31%
General and Administrative Expense $8,254,466 USD 54%
Operating Income (Loss) $11,887,459 USD 68%
Nonoperating Income (Expense) $0 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $12,052,215 USD 68%
Earnings Per Share, Basic 10 USD/shares 51%
Earnings Per Share, Diluted 10 USD/shares 51%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,096,909 USD 9.9%
Other Assets, Current $250,340 USD 184%
Assets, Current $1,588,577 USD -24%
Property, Plant and Equipment, Net $22,502,158 USD -1.5%
Other Assets, Noncurrent $28,476 USD 0%
Assets $25,445,540 USD -4.2%
Accounts Payable, Current $18,968,173 USD -16%
Liabilities, Current $26,860,206 USD -11%
Deferred Income Tax Liabilities, Net $40,909 USD -72%
Liabilities $27,552,737 USD -25%
Retained Earnings (Accumulated Deficit) $109,235,078 USD -12%
Stockholders' Equity Attributable to Parent $2,107,197 USD 79%
Liabilities and Equity $25,445,540 USD -4.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,513,856 USD 2.5%
Net Cash Provided by (Used in) Financing Activities $53,103 USD -101%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 2,621,607 shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,566,959 USD -829%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,096,909 USD 9.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities $244,269 USD
Deferred Tax Assets, Valuation Allowance $26,228,354 USD 43%
Deferred Tax Assets, Gross $26,269,263 USD 42%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $343,193 USD
Property, Plant and Equipment, Gross $26,586,327 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Two $49,349 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $293,844 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $107,127,619 USD 23%
Depreciation, Depletion and Amortization $419,010 USD 72%
Interest Expense $854,019 USD 121%